Antibody-drug conjugate trial starts
Global, 2020 to 2025
349
2025
Antibody-drug conjugate trial starts: Global, 2020 to 2025
Antibody-drug conjugate trial starts: Global, 2020 to 2025. 6 observations from 2020 to 2025, ranging from 101 to 349. Latest value 349 (2025).
0
100
200
300
400
2020
2021
2022
2023
2024
2025
101
349
Antibody-drug conjugate trial starts: Global, 2020 to 2025
Antibody-drug conjugate trial starts: Global, 2020 to 2025. 6 observations from 2020 to 2025, ranging from 101 to 349. Latest value 349 (2025).
0
100
200
300
400
2020
2021
2022
2023
2024
2025
101
349
Antibody-drug conjugate trial starts: Global, 2020 to 2025
Antibody-drug conjugate trial starts: Global, 2020 to 2025. 6 observations from 2020 to 2025, ranging from 101 to 349. Latest value 349 (2025).
0
100
200
300
400
2020
2021
2022
2023
2024
2025
101
349
View the underlying data
Antibody-drug conjugate trial starts: Global, 2020 to 2025
Period
Type
Value
2020
Actual
101
2021
Actual
145
2022
Actual
176
2023
Actual
233
2024
Actual
282
2025
Actual
349
Chart:
StatOrigin
· Source: ClinicalTrials.gov ·
statorigin.org
CC BY 4.0